| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/27/1984 | EP0112093A2 Novel monoclonal hybridoma and corresponding antibody |
| 06/21/1984 | WO1984002351A1 A process for preparing ripe proteins from fusion proteins, synthetized in pro- or eukaryotic cells |
| 06/20/1984 | EP0111344A2 Anti-interleukin-2 monoclonal antibodies |
| 06/13/1984 | EP0110791A2 Peptides containing an immunogenic site of the poliovirus, and DNA's containing nucleotide fragments encoding for these peptides |
| 06/13/1984 | EP0110716A2 Monoclonal antibodies against melanocytes and melanomas |
| 06/13/1984 | EP0110706A2 Injection of anti-idiotype to elecit immune response to infectious viral agents |
| 06/13/1984 | EP0110385A2 Process for producing poxvirus recombinants for expression of foreign genes |
| 06/13/1984 | EP0110302A2 Method for producing monomeric interferons |
| 06/13/1984 | EP0110044A1 Human immune interferon protein and production thereof |
| 06/07/1984 | WO1984002194A1 IgA BINDING ANTIBODY |
| 06/07/1984 | WO1984002129A1 Human immune interferon protein and process for its preparation |
| 06/07/1984 | WO1984002077A1 Process for producing poxvirus recombinants for expression of foreign genes |
| 06/05/1984 | US4452782 Immunopotentiating agents |
| 06/05/1984 | CA1168602A1 Plasmid vectors, production and use thereof |
| 05/30/1984 | EP0109748A1 Pharmaceutical and veterinary preparations of cystein-125-depleted muteins of Interleukin-2 and their production |
| 05/30/1984 | EP0109560A2 Yeast plasmid vector capable of induced expressing and method of using said plasmid |
| 05/30/1984 | EP0109559A1 High-efficiency yeast vector plasmid and method of its use |
| 05/29/1984 | US4451487 Process for the purification or enrichment of biologically active proteins |
| 05/29/1984 | US4451456 Antitumor antibacterial agents |
| 05/29/1984 | CA1168151A1 Interferon proteins and method of producing same |
| 05/24/1984 | WO1984001961A1 Recombinant dna derived antigens of treponema pallidum |
| 05/23/1984 | EP0109150A2 Plasmids with conditional uncontrolled replication behaviour |
| 05/23/1984 | EP0108872A1 Novel cloning vectors |
| 05/23/1984 | EP0108787A1 The manufacture and expression of structural genes. |
| 05/22/1984 | US4450103 Process for recovering human IFN-β from a transformed microorganism |
| 05/16/1984 | EP0108667A1 Cell lines originating from mammals, producers of growth hormone, preferentially human growth hormone, and vectors for obtaining them |
| 05/16/1984 | EP0108633A2 Assay for qualitatively and/or quantitatively measuring hLH or hCG in body fluids and reagents therefor |
| 05/16/1984 | EP0108585A2 Method for removing impurities from leukocyte interferon preparations, and purified leukocyte iterferon produced thereby |
| 05/16/1984 | EP0108564A1 Methods for oncogenic detection |
| 05/16/1984 | EP0108387A1 Preparation of recombinant growth releasing factors |
| 05/16/1984 | EP0108146A1 Fused genes encoding hybrid proteins, cloning vectors containing them and the use thereof. |
| 05/16/1984 | EP0048283B1 Virus-inhibiting substance and process for preparing the same |
| 05/15/1984 | US4448885 Bacillus thuringiensis crystal protein in Escherichia coli |
| 05/15/1984 | US4448879 High yield process for in vitro production of serum-free and mitogen-free interleukin-2 |
| 05/15/1984 | US4448768 Antigenic protein |
| 05/15/1984 | US4448714 Bactericidal and bacteriolytic action against grampositive bacteria |
| 05/15/1984 | CA1167399A1 Production of protein with reduced nucleic acid |
| 05/15/1984 | CA1167398A1 Microparticles, preparation thereof and applications thereof in biology, particularly in the culture of human diploid cells |
| 05/10/1984 | WO1984001714A1 Novel plasminogen activator, process for its preparation, and thrombolytic drug containing the same |
| 05/08/1984 | CA1166983A1 Method and means for microbial polypeptide expression |
| 05/08/1984 | CA1166959A1 Method for the purification of interferon |
| 05/03/1984 | EP0108146A4 Fused genes encoding hybrid proteins, cloning vectors containing them and the use thereof. |
| 05/02/1984 | EP0107528A2 Human nonsecretory plasmacytoid cell line |
| 05/02/1984 | EP0107509A2 Protein A material and preparation thereof |
| 05/02/1984 | EP0107436A1 Polypeptides useful in vaccination against enteroviruses |
| 05/02/1984 | EP0107400A1 Hybrid plasmid and process for producing glutathione using said plasmid |
| 05/01/1984 | US4446235 Method for cloning human growth hormone varient genes |
| 04/26/1984 | WO1984001575A1 Polypeptides useful in vaccination against enteroviruses |
| 04/25/1984 | EP0106828A2 Recombinant DNA molecules encoding for hepatitis B surface antigen, their preparation and derived vaccines |
| 04/25/1984 | EP0106542A2 Plasmid stabilization |
| 04/25/1984 | EP0106179A1 Homogeneous human-interleukin-2 and process for its preparation |
| 04/25/1984 | EP0106170A2 Avian growth hormone |
| 04/25/1984 | EP0106146A1 Process for the biological preparation of glutathione |
| 04/24/1984 | US4444878 Bispecific antibody determinants |
| 04/18/1984 | EP0105804A2 Human monoclonal antibodies against bacterial toxins |
| 04/18/1984 | EP0105608A1 Method of protecting bacteria |
| 04/18/1984 | EP0105521A2 Novel DNA, microorganism transformed therewith and use thereof |
| 04/17/1984 | US4443540 Protein hydrolysis |
| 04/17/1984 | US4443539 Process for preparing bovine growth hormone |
| 04/17/1984 | US4443427 Monoclonal antibody |
| 04/17/1984 | CA1165711A1 Method for treating a casein-based raw material containing phosphocaseinates of bivalent cations, resulting products and applications thereof |
| 04/17/1984 | CA1165685A1 Purified prostatic tissue antigen |
| 04/12/1984 | WO1984001389A1 Characterization of oncogenes and assays based thereon |
| 04/11/1984 | EP0105141A2 Recombinant DNA molecules, process for their production, their use for production of hepatitis B surface antigen (HBsAg) and pharmaceutical compositions containing this HBsAg |
| 04/10/1984 | US4442085 Protection against dental caries |
| 04/04/1984 | EP0104920A1 DNA sequences, recombinant DNA molecules and processes for producing swing growth hormone-like polypeptides |
| 04/04/1984 | EP0104217A1 CODING DNA FRAGMENTS FOR POLYPEPTIDES CONTAINING AT LEAST ONE ANTIGENIC DETERMINANT OF THE PAPILLOMAVIRUS PARTICULARLY OF THE la HPV TYPE AND CORRESPONDING POLYPEPTIDES. |
| 04/03/1984 | US4440853 Microbiological methods using hollow fiber membrane reactor |
| 04/03/1984 | US4440675 Human immune interferon |
| 03/29/1984 | WO1984001172A1 Stabilized plasmids |
| 03/29/1984 | WO1984001171A1 Plasmids with conditional uncontrolled replication behaviour |
| 03/29/1984 | WO1984001150A1 Avian growth hormones |
| 03/29/1984 | WO1984001149A1 Novel polypeptide and its use |
| 03/28/1984 | EP0104061A1 Improved expression vectors |
| 03/28/1984 | EP0103960A2 DNA sequences coding for the DR beta-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto |
| 03/28/1984 | EP0103898A1 Novel peptide and use thereof |
| 03/28/1984 | EP0103632A1 Method for introducing cloned, amplifiable genes into eucaryotic cells and for producing proteinaceous products. |
| 03/27/1984 | CA1164375A1 Microbial expression of quasi-synthetic genes |
| 03/21/1984 | EP0103409A2 Glycolytic promoters for regulated protein expression: protease inhibitor |
| 03/21/1984 | EP0103395A2 DNA sequences, recombinant DNA molecules and processes for producing bovine growth hormone-like polypeptides in high yield |
| 03/21/1984 | EP0103368A2 Monoclonal antibodies for human tissue cross-matching, a diagnostic kit containing them, hybridomas for producing them and a method for producing the hybridomas |
| 03/20/1984 | US4438208 Region-specific determinants for vitamin K dependent bone protein |
| 03/14/1984 | EP0102634A1 Recombinant DNA, microorganism transformed therewith and use thereof |
| 03/14/1984 | EP0102601A2 Monoclonal antibody, a process for its production and the use of this monoclonal antibody |
| 03/14/1984 | EP0102529A2 Process for preparation of aspartylphenylalanine alkyl esters |
| 03/14/1984 | EP0102499A1 High potency, mycelial-free avoparcin alkyl sulfate complex, & method for the preparation thereof |
| 03/14/1984 | EP0102436A1 Method for the treatment of organic wastes comprising the separation of toxic materials |
| 03/13/1984 | US4436815 Method for stabilizing and selecting recombinant DNA containing host cells |
| 03/13/1984 | US4436726 N-Acylpeptide compound, processes for the preparation thereof and the pharmaceutical compositions |
| 03/13/1984 | CA1163585A1 Nucleotidic sequence coding the surface antigen of the hepatitis b virus, carrier containing the nucleotidic sequence, preparation process and antigen so obtained |
| 03/07/1984 | EP0102228A2 Hybridoma secreting a monoclonal antibody specific for 5-bromo and 5-iododeoxyuridine and reagent for measuring cellular proliferation |
| 03/01/1984 | WO1984000775A1 The use of eucaryotic promoter sequences in the production of proteinaceous materials |
| 03/01/1984 | WO1984000774A1 Staphylococcal protein a coding gene (dna) fragment comprising a signal dna sequence, a process for its preparation and a microorganism transformed therewith |
| 03/01/1984 | WO1984000773A1 Recombinant dna molecule, transformed microorganism and process for producing staphylococcal protein a |
| 02/29/1984 | EP0101617A2 Recombinant DNA containing a hepatitis B virus gene, mammalian cells transformed with the cloned viral DNA, and production of hepatitis B virus proteins |
| 02/28/1984 | US4434230 Hybridomas with lymphocytes |
| 02/28/1984 | US4434156 Monoclonal antibodies specific for the human transferrin receptor glycoprotein |
| 02/28/1984 | CA1162868A1 Process for preparing insulin esters |
| 02/22/1984 | EP0101363A1 Process for separating lymphocyte activating factors from a cellular incubation medium, especially a granulocyte-macrophage cell line, by antigen-antibody reaction with anti-MDP antibodies |
| 02/22/1984 | EP0101309A2 Molecular cloning and characterization of a gene sequence coding for human relaxin |